SSTR-PeRForm: A harmonized approach to somatostatin receptor PET response assessment in neuroendocrine tumors. [PDF]
Leupe H +4 more
europepmc +1 more source
Compare Serum VCAM‐1, NSE, Procalcitonin in Predict Sepsis Induced Encephalopathy in Septic Patients
Serum VCAM‐1 is associated with septic encephalopathy in the first 7 days of sepsis. NSE and procalcitonin were not associated with septic encephalopathy. ABSTRACT Background Sepsis‐associated encephalopathy (SAE) is a common complication of severe sepsis. Increased concentration of Vascular Cell Adhesion Molecule 1 (VCAM‐1) is associated with SAE in a
Chun‐Fu Lin +2 more
wiley +1 more source
Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors. [PDF]
De Cannière G +7 more
europepmc +1 more source
The Enteric Nervous System: An Integrative Hub From Development to Systemic Physiology
Unlike a static hardwired circuit, the ENS continuously remodels its transcriptional programs and synaptic connectivity in response to three ecological forces: microbial metabolites, immune cell signals and enteroendocrine cues. ABSTRACT The enteric nervous system (ENS) constitutes the largest and most functionally autonomous subdivision of the ...
Mario Cuchillo‐Hilario +3 more
wiley +1 more source
Laparoscopic resection of small bowel neuroendocrine tumors: A long-term survival analysis. [PDF]
Perets M +6 more
europepmc +1 more source
Molecular theranostics: principles, challenges and controversies
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
Editorial: Innovative diagnostic and therapeutic strategies for neuroendocrine tumors: a multidisciplinary approach. [PDF]
Borges de Souza P +5 more
europepmc +1 more source
Perioperative Risks of Concurrent Pancreatic and Hepatic Resections for Neuroendocrine Tumors
ABSTRACT Background and Objectives Pancreatic neuroendocrine tumors (pNETs) account for 1%–2% of pancreatic tumors, with an increasing incidence. The safety of concurrent pancreas‐liver resections remains uncertain. This study evaluated the national outcomes of concurrent pancreatectomy and liver‐directed surgery for pNETs. Methods ACS‐NSQIP (2019–2023)
Amir Ebadinejad +4 more
wiley +1 more source
Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review. [PDF]
Shekhda KM +23 more
europepmc +1 more source
ABSTRACT Introduction Advances in neoadjuvant therapy and surgical techniques have led to more total pancreatectomies (TP) with vascular resection for pancreatic cancer. This study assesses contemporary outcomes of TP with venous (VR) and arterial (AR) resections compared to non‐vascular resection (NVR).
Zofia Czarnecka +3 more
wiley +1 more source

